Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Odds Ratio01:09

Odds Ratio

The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ShinyDataMatcher: A user-friendly application for integrating survey data.

PloS one·2026
Same author

Bayesian Analysis of ANOVA and Mixed Models on the Log-Transformed Response Variable.

Psychometrika·2021
Same author

Bayesian inference for quantiles of the log-normal distribution.

Biometrical journal. Biometrische Zeitschrift·2020
Same author

In vivo and in vitro effects of selected antioxidants on rabbit meat microbiota.

Meat science·2016
Same author

Biodiversity among Lactobacillus helveticus strains isolated from different natural whey starter cultures as revealed by classification trees.

Applied and environmental microbiology·2004

Related Experiment Video

Updated: Jun 24, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

A multivariate CAR model for improving the estimation of relative risks.

Fedele P Greco1, Carlo Trivisano

  • 1Department of Statistics P. Fortunati, University of Bologna, Italy. fedele.greco@unibo.it

Statistics in Medicine
|March 25, 2009
PubMed
Summary

This study introduces a new multivariate disease mapping model, improving upon existing methods by relaxing restrictive assumptions. The model effectively analyzes multiple diseases simultaneously for better epidemiological insights.

Related Experiment Videos

Last Updated: Jun 24, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Area of Science:

  • Spatial statistics
  • Epidemiology
  • Biostatistics

Background:

  • Univariate disease mapping is common, analyzing one disease at a time.
  • Simultaneous modeling of multiple diseases offers significant epidemiological and statistical advantages.

Purpose of the Study:

  • To propose a novel multivariate disease mapping model.
  • To generalize the univariate conditional auto-regressive (CAR) distribution for multiple diseases.
  • To overcome limitations of existing multivariate disease mapping models.

Main Methods:

  • Developed a generalized conditional auto-regressive (CAR) model for multivariate disease mapping.
  • Evaluated model performance through a comprehensive simulation study.
  • Applied the model to a real-world case study for practical validation.

Main Results:

  • The proposed multivariate CAR model demonstrated effectiveness in disease mapping.
  • The model successfully relaxed restrictive assumptions present in previous multivariate approaches.
  • Simulation and case study results confirmed the model's utility and performance.

Conclusions:

  • The novel multivariate disease mapping model provides a powerful alternative to existing methods.
  • This approach enhances the ability to study spatial patterns of multiple diseases concurrently.
  • The model offers improved statistical properties and broader applicability in epidemiological research.